The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long-term tinzaparin versus warfarin for treatment: The CATCH study.
 
Alok A. Khorana
Honoraria - AngioDynamics; Daiichi Sankyo; Genentech; Johnson & Johnson; LEO Pharma; Sanofi
Consulting or Advisory Role - AngioDynamics; Daiichi Sankyo; Genentech; Johnson & Johnson; LEO Pharma; Sanofi
Research Funding - LEO Pharma
 
Rupert Bauersachs
No Relationships to Disclose
 
Pieter W Kamphuisen
Honoraria - LEO Pharma
Consulting or Advisory Role - LEO Pharma
Research Funding - Boehringer Ingelheim; LEO Pharma; Pfizer
 
Guy Meyer
Research Funding - Bayer; Boehringer Ingelheim; LEO Pharma; Sanofi
 
Mette S. Janas
Employment - LEO Pharma
 
Mikala F. Jarner
Employment - LEO Pharma
 
Agnes Y. Lee
Honoraria - Aviva; Boehringer Ingelheim; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Daiichi Sankyo; LEO Pharma; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst)